☰

Jieya Shao, Ph.D. - Publications

Affiliations: 
2002 Oklahoma State University, Stillwater, OK, United States 
Area:
Biochemistry, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wang F, Zhu C, Cai S, Boudreau A, Kim SJ, Bissell M, Shao J. Ser Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity. Frontiers in Cell and Developmental Biology. 9: 692269. PMID 34235154 DOI: 10.3389/fcell.2021.692269  0.331
2020 Zhu C, Rogers A, Asleh K, Won J, Gao D, Leung S, Li S, Vij KR, Zhu J, Held JM, You Z, Nielsen TO, Shao J. Phospho-Ser-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer. Cell Reports. 31: 107745. PMID 32521270 DOI: 10.1016/J.Celrep.2020.107745  0.351
2018 Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, et al. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Reports. 24: 1434-1444.e7. PMID 30089255 DOI: 10.1016/J.Celrep.2018.07.009  0.312
2018 Gates LA, Gu G, Chen Y, Rohira AD, Lei JT, Hamilton RA, Yu Y, Lonard DM, Wang J, Wang SP, Edwards DG, Lavere PF, Shao J, Yi P, Jain A, ... ... Shao J, et al. Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets. Oncogene. PMID 29748621 DOI: 10.1038/S41388-018-0284-2  0.378
2018 Lei J, Shao J, Zhang J, Iglesia M, Chan D, Cao J, Anurag M, Singh P, Haricharan S, Kavuri S, Matsunuma R, Schmidt C, Kosaka Y, Crowder R, Hoog J, et al. Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd8-03  0.31
2017 Lei J, Shao J, Zhang J, Iglesia M, Cao J, Chan D, He X, Kosaka Y, Schmidt C, Matsunuma R, Haricharan S, Crowder R, Hoog J, Phommaly C, Goncalves R, et al. Abstract PD2-03: Recurrent functionally diverse in-frameESR1gene fusions drive endocrine resistance in breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd2-03  0.321
2015 Wardell SE, Ellis MJ, Alley HM, Eisele K, VanArsdale T, Dann SG, Arndt KT, Primeau T, Griffin E, Shao J, Crowder RJ, Lai JP, Norris JD, McDonnell DP, Li S. Efficacy of SERD/SERM Hybrid-CDK4/6 inhibitor combinations in models of endocrine therapy resistant breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25991817 DOI: 10.1158/1078-0432.Ccr-15-0360  0.33
2015 Diamond MI, Cai S, Boudreau A, Carey CJ, Lyle N, Pappu RV, Swamidass SJ, Bissell M, Piwnica-Worms H, Shao J. Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. The Journal of Biological Chemistry. 290: 9075-86. PMID 25681442 DOI: 10.1074/Jbc.M114.619874  0.401
2015 Shao J, Zhang J, Crowder RJ, Goncalves R, Phommaly C, Awg B, Perou CM, Maher CA, Thompson EA, Ellis MJ. Abstract PD6-4: ESR1 gene fusions implicated in endocrine therapy resistance of ER+ breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd6-4  0.32
2014 Udan-Johns M, Bengoechea R, Bell S, Shao J, Diamond MI, True HL, Weihl CC, Baloh RH. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Human Molecular Genetics. 23: 157-70. PMID 23962724 DOI: 10.1093/Hmg/Ddt408  0.421
2014 Sen T, Li S, Shao J, Crowder R, Kitchens R, Ellis MJ. Abstract 5544: Patient-derived xenograft study reveals the pharmacology and the role of ESR1 gene aberrations in endocrine therapy resistance of ER positive breast cancer Cancer Research. 74: 5544-5544. DOI: 10.1158/1538-7445.Am2014-5544  0.323
2013 Shao J, Li S, Crowder R, Kitchens R, Johnson S, Goncalves R, Phommaly C, Griffith O, Maher C, Perou C, Mardis E, Ellis M. Abstract S3-05: Patient-derived xenograft study reveals endocrine therapy resistance of ER+ breast cancer caused by distinct ESR1 gene aberrations Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-S3-05  0.318
2012 Shao J, Diamond MI. Protein phosphatase 1 dephosphorylates profilin-1 at Ser-137. Plos One. 7: e32802. PMID 22479341 DOI: 10.1371/Journal.Pone.0032802  0.503
2010 Angeli S, Shao J, Diamond MI. F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics. Plos One. 5: e9053. PMID 20140226 DOI: 10.1371/Journal.Pone.0009053  0.35
2010 Rossetti G, Magistrato A, Pastore A, Angeli S, Shao J, Diamond MI, Carloni P. Huntingtin: Stability and Interaction with Molecular Partner from Computational Biophysics Studies Biophysical Journal. 98: 637a. DOI: 10.1016/J.Bpj.2009.12.3490  0.314
2008 Chandra S, Shao J, Li JX, Li M, Longo FM, Diamond MI. A common motif targets huntingtin and the androgen receptor to the proteasome. The Journal of Biological Chemistry. 283: 23950-5. PMID 18586675 DOI: 10.1074/Jbc.M800467200  0.375
2008 Shao J, Welch WJ, Diprospero NA, Diamond MI. Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation. Molecular and Cellular Biology. 28: 5196-208. PMID 18573880 DOI: 10.1128/Mcb.00079-08  0.44
2008 Shao J, Welch WJ, Diamond MI. ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation. Febs Letters. 582: 1637-42. PMID 18423405 DOI: 10.1016/J.Febslet.2008.04.009  0.441
2007 Shao J, Diamond MI. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Human Molecular Genetics. 16: R115-23. PMID 17911155 DOI: 10.1093/Hmg/Ddm213  0.343
2005 Prince T, Shao J, Matts RL, Hartson SD. Evidence for chaperone heterocomplexes containing both Hsp90 and VCP. Biochemical and Biophysical Research Communications. 331: 1331-7. PMID 15883021 DOI: 10.1016/J.Bbrc.2005.04.047  0.693
2003 Pollitt SK, Pallos J, Shao J, Desai UA, Ma AA, Thompson LM, Marsh JL, Diamond MI. A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron. 40: 685-94. PMID 14622574 DOI: 10.1016/S0896-6273(03)00697-4  0.357
2003 Shao J, Irwin A, Hartson SD, Matts RL. Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding. Biochemistry. 42: 12577-88. PMID 14580204 DOI: 10.1021/Bi035138J  0.719
2003 Scroggins BT, Prince T, Shao J, Uma S, Huang W, Guo Y, Yun BG, Hedman K, Matts RL, Hartson SD. High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. Biochemistry. 42: 12550-61. PMID 14580201 DOI: 10.1021/Bi035001T  0.727
2003 Shao J, Prince T, Hartson SD, Matts RL. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. The Journal of Biological Chemistry. 278: 38117-20. PMID 12930845 DOI: 10.1074/Jbc.C300330200  0.729
2002 Shao J, Hartson SD, Matts RL. Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2alpha kinase. Biochemistry. 41: 6770-9. PMID 12022881 DOI: 10.1021/Bi025737A  0.733
2001 Shao J, Grammatikakis N, Scroggins BT, Uma S, Huang W, Chen JJ, Hartson SD, Matts RL. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase. The Journal of Biological Chemistry. 276: 206-14. PMID 11036079 DOI: 10.1074/Jbc.M007583200  0.753
2000 Scholz G, Hartson SD, Cartledge K, Hall N, Shao J, Dunn AR, Matts RL. p50(Cdc37) can buffer the temperature-sensitive properties of a mutant of Hck. Molecular and Cellular Biology. 20: 6984-95. PMID 10958693 DOI: 10.1128/Mcb.20.18.6984-6995.2000  0.729
2000 Hartson SD, Irwin AD, Shao J, Scroggins BT, Volk L, Huang W, Matts RL. p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules. Biochemistry. 39: 7631-44. PMID 10858314 DOI: 10.1021/Bi000315R  0.758
Show low-probability matches.